Biotechnology Industry Immersion
Fridays, 9 a.m. to 4 p.m., 1302 Gallagher
Biotechnology has been a disruptive technology in the life sciences industry, especially in biomedical therapeutics and diagnostics. Continued success in the biotechnology industry requires the application of extraordinary leadership and management skills in addition to the scientific innovations.
- Curriculum designed by both UC Davis faculty and industry executives to reflect the latest challenges in the industry
- Gain hands-on experience each week, teaming with MBA and biotech sciences students in problem-solving sessions
- Five weeks of interactive classes on Fridays in Winter Quarter taught by senior executives from a select group of companies
- Group assignments in every class, examining potential solutions to management challenges
Speakers & Topics
This course introduces students to the many facets of the biotechnology industry and provides a framework for understanding the complex forces that shape and drive it.
You’ll learn from top industry executives about:
- Growth and new developments
- Drug innovations
- Drug regulations
- Marketing and commercialization
|Friday, January 12, 2018|
|Judith A. Kjelstrom, PhD
Director, UC Davis Biotechnology
Program Coordinator, Designated Emphasis in Biotechnology Graduate Program
Lecturer, Microbiology and Molecular & Cell Biology
|PM Session||An Introduction to Drug Development|
Lonnie Bookbinder, Ph.D., MBA
Founder and CEO
ARIZ Precision Medicine
|Friday, January 19, 2018|
|AM Session||Growing a Small Company: Access to Financial and Human Capital|
Glenn Nedwin, Ph.D.
CEO & President
Second Genome, Inc.
|PM Session||Issues Encountered when expanding Partnerships and Markets|
President and Founder
|Friday, January 26, 2018|
|AM Session||Challenges of the Government Approval Process|
Sharon Barclay Kime, J.D., MPH, BSN
US Head of Regulatory Intelligence
|PM Session||7 Tips for Entrepreneurs|
Craig Shimasaki, Ph.D., MBA
President and CEO
|Friday, February 2, 2018|
|AM Session||Marketing and Commercialization of Drugs and Products|
Jonathan Piazza (tentative)
Healthcare Investment Banking
Barclays Investment Bank
|PM Session||Supply Chain Issues|
Charles Calderaro III
Senior Vice President, Global Manufacturing
|Friday, February 9, 2018|
|AM Session||Innovations in the Future: Precision Medicine Using Big Data Analytics|
Jeff Welser, Ph.D.
VP and Lab Director
IBM Research – Almaden
|PM Session||Innovations in the Future: Stem Cells and Targeted Therapies|
Christopher Murriel, Ph.D.
Department of Cancer Biology
OncoMed Pharmaceuticals, Inc.